Exploring the genetics of airflow limitation in lung function across the lifespan - a polygenic risk score study.

Hernandez-Pacheco, Natalia; Kilanowski, Anna; Kumar, Ashish; Curtin, John A; Olvera, Núria; Kress, Sara; Bertels, Xander; Lahousse, Lies et al. · EClinicalMedicine · 2024

meta_analysis · Level II

Where this comes from

Abstract

Chronic obstructive pulmonary disease (COPD) is caused by interactions between many factors across the life course, including genetics. A proportion of COPD may be due to reduced lung growth in childhood. We hypothesized that a polygenic risk score (PRS) for COPD is associated with lower lung function already in childhood and up to adulthood. A weighted PRS was calculated based on the 82 association signals (<i>p</i> ≤ 5 × 10<sup>-8</sup>) revealed by the largest GWAS of airflow limitation (defined as COPD) to date. This PRS was tested in association with lung function measures (FEV<sub>1</sub>, FVC, and FEV<sub>1</sub>/FVC) in subjects aged 4-50 years from 16 independent cohorts participating in the Chronic Airway Diseases Early Stratification (CADSET) Clinical Research Collaboration. Age-stratified meta-analyses were conducted combining the results from each cohort (n = 45,406). These findings were validated in subjects >50 years old. We found significant associations between the PRS for airflow limitation and: <i>(1)</i> lower pre-bronchodilator FEV<sub>1</sub>/FVC from school age (7-10 years; β: -0.13 z-scores per one PRS z-score increase [-0.15, -0.11], <i>q</i>-value = 7.04 × 10<sup>-53</sup>) to adulthood (41-50 years; β: -0.16 [-0.19, -0.13], <i>q</i>-value = 1.31 × 10<sup>-24</sup>); and <i>(2)</i> lower FEV<sub>1</sub> (from school age: 7-10 years; β: -0.07 [-0.09, -0.05], <i>q</i>-value = 1.65 × 10<sup>-9</sup>, to adulthood: 41-50 years; β: -0.17 [-0.20, -0.13], <i>q</i>-value = 4.48 x 10<sup>-20</sup>). No effect modification by smoking, sex, or a diagnosis of asthma was observed. We provide evidence that a higher genetic risk for COPD is linked to lower lung function from childhood onwards. This study was supported by CADSET, a Clinical Research Collaboration of the European Respiratory Society.